Paras Healthcare Limited (PARASHLTH.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-146.2%

-₹335.23

vs ₹725.70 price

Levered DCF

-₹614.27

After debt service

Piotroski score

—

Altman Z-score

—

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022
P/E	181.63×	-137.24×	-518.03×	-186.23×
P/B	20.15×	28.38×	23.51×	264.38×
P/S	4.96×	6.15×	7.05×	8.68×
EV / EBITDA	27.81×	59.76×	58.3×	102.28×
Gross margin	35.5%	28.8%	28.5%	29.0%
Operating margin	10.9%	1.8%	3.6%	6.4%
Net margin	2.7%	-4.5%	-1.4%	-4.7%
Current ratio	1.08×	0.84×	0.89×	0.55×
Debt / equity	3.53×	4.39×	2.73×	25.1×
Interest coverage	1.52×	0.27×	0.63×	1.27×
Dividend yield	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022
Return on equity	11.1%	-20.7%	-4.5%	-142.1%
Return on invested capital	5.6%	1.6%	-7.4%	7.5%
Return on assets	2.1%	-3.2%	-1.0%	-3.3%
Free cash flow yield	-0.1%	-0.6%	-1.3%	-0.9%
Earnings yield	0.6%	-0.7%	-0.2%	-0.5%
Enterprise value	₹93.1B	₹91.5B	₹88.7B	₹86.9B
Net debt / EBITDA	4.02×	7.8×	5.97×	8.62×
Cash conversion cycle (days)	27	13	9	0